Loading...

Building on the success of MitoXpress® Xtra Oxygen Consumption Assay, Luxcel Biosciences has created and is rapidly expanding a one-stop-shop of in vitro cell-based assay tests and kits, targeting Cell Metabolism, Drug Safety and Hypoxia / Oxidative Stress for the Life Sciences market.  These 96- and 384-well microtitre-based fluorescence assays measure essential cellular metabolic pathways, and are configured for use on standard fluorescence plate readers, providing easy-to-use solutions for basic research, drug discovery and safety toxicology.

Luxcel Biosciences is an award winning developer of innovative optical fluorescence test solutions, used by scientists and technicians from Universities to global Pharmaceutical Companies, with a proven ability to transform existing specialised tests, into new, high performance but affordable and easy-to-use products. Unlike traditional tests, our solutions provide broad customer application, without the need for dedicated, expensive instrumentation.

We are a young and motivated team, with a shared passion of enabling and supporting our customers, to get the best possible results from the use of our products.

Some of the team

A HISTORY OF INNOVATION

2006

MitoXpress® Xtra - 1st high throughput OCR test, for the measurement of mitochondrial toxicity in the Pharmaceutical industry.

2009

OpTech® - 1st handheld reader for non-invasive measurement of oxygen in the Packaging industry.

2010

GreenLight® - 1st reagent-free system for real-time measurement of microbial contamination in the Food and Beverage industry.

2016

MetaCell a Gold Standard platform, comprising cell assays, disease models and services, with high performance metabolism tests designed for use on laboratory standard instrumentation.